Vernalis (VER)

 

Latest News

Vernalis sales beat market expectations

Vernalis reported revenue of 20.8m (2016: 12m), which was ahead of market expectations in the year to 30 June 2017. US CO...

Results Announcement for the Year Ended 30/06/2017

RNS Number: 4293Q Vernalis PLC 12 September 2017 12 September 2017 LSE: VER Vernalis plc Results Announcement for the year ended 30 June 2017 Tuzistra XR prescriptions growing steadily In-house salesforce to promote both Tuzistra XR and Moxatag for the coming season Independent market research continues to show significant market opportunity for co...

FDA Issues Complete Response Letter on CCP-08 NDA

RNS Number: 2148N Vernalis PLC 07 August 2017 07 August 2017 LSE: VER FDA Issues a Complete Response Letter on CCP-08 NDA Vernalis plc announced today that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for CCP-08. A CRL is issued by the FDA when it has comple...

Broker Forecast - Cantor Fitzgerald issues a broker note on Vernalis PLC

Cantor Fitzgerald today reaffirms its buy investment rating on Vernalis PLC (LON:VER) and cut its price target to 81p (fr...

All News

DateHeadlineSource
12-09-17Vernalis sales beat market expectationsStockMarketWire
12-09-17Results Announcement for the Year Ended 30/06/2017RNS
07-08-17FDA Issues Complete Response Letter on CCP-08 NDARNS
28-07-17Broker Forecast - Cantor Fitzgerald issues a broker note on Vernalis PLCStockMarketWire
18-07-17Vernalis anticipates sales to be expectationsStockMarketWire
18-07-17Year-End Trading Update and Notice of ResultsRNS
30-06-17Total Voting RightsRNS
31-05-17Total Voting RightsRNS
28-04-17Total Voting RightsRNS
26-04-17Vernalis and Servier announce three milestonesStockMarketWire
26-04-17Servier and Vernalis announce 3 milestonesRNS
21-04-17Broker Forecast - Panmure Gordon issues a broker note on Vernalis PLCStockMarketWire
21-04-17Broker Forecast - Stifel issues a broker note on Vernalis PLCStockMarketWire
21-04-17FTSE struggles as dominant blue-chips fall StockMarketWire
21-04-17FTSE ahead as miners up with industrial metals pricesStockMarketWire
21-04-17Vernalis to resubmit NDA to US FDA for drug CCP-07StockMarketWire
21-04-17Vernalis receives $2 million milestone paymentRNS
21-04-17FDA Issues Complete Response Letter on CCP-07 NDARNS
04-04-17Broker Forecast - Stifel issues a broker note on Vernalis PLCStockMarketWire
29-03-17Block listing Interim ReviewRNS
20-03-17Broker Forecast - N+1 Singer issues a broker note on Vernalis PLCStockMarketWire
06-03-17Vernalis, Servier in new drug discovery collaborationStockMarketWire
06-03-17New drug discovery collaboration with ServierRNS
28-02-17Total Voting RightsRNS
21-02-17Unaudited interim results for 6 months to 31/12/16RNS
14-02-17Broker Forecast - Stifel issues a broker note on Vernalis PLCStockMarketWire
14-02-17Achievement of a $3m milestone payment from CorvusRNS
30-01-17Vernalis schedules interimsStockMarketWire
30-01-17Notice of Results for Six Months Ended 31/12/2016RNS
25-01-17Versarien Plc to present at the Shares Spotlight Evening in London on 9 February 2017StockMarketWire
21-12-16Vernalis says FDA accepts CCP-08 NDA for full reviewStockMarketWire
21-12-16FDA accepts CCP-08 NDA for full reviewRNS
01-12-16Broker Forecast - Panmure Gordon issues a broker note on Vernalis PLCStockMarketWire
01-12-16Vernalis Results of Annual General MeetingRNS
01-12-16Vernalis says business progressing in line with viewsStockMarketWire
01-12-16AGM StatementRNS
11-11-16AIM shares touched by the 'Trump effect' Interactive Investor
03-11-16Holding(s) in CompanyRNS
31-10-16Total Voting RightsRNS
24-10-16Notice of Annual Report and AGMRNS

RSS feeds

  • Editorial news feed for LSE:VER Editorial
  • Regulatory news feed for LSE:VER Regulatory